18.17

1.68% 0.30

After Hours: 18.17

Integra Lifesciences Holdings Corp (IART)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Integra Lifesciences Holdings Corp stock is traded at $18.17, with a volume of 584.35K. It is up +1.68% in the last 24 hours and down -10.67% over the past month. Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Previous Close:

$17.87

Open:

$18.1

24h Volume:

584.35K

Relative Volume:

0.47

Market Cap:

$1.40B

Revenue:

$1.53B

Net Income/Loss:

$40.23M

P/E Ratio:

15.02

EPS:

1.21

Net Cash Flow:

$60.93M

1W Performance:

+3.59%

1M Performance:

-10.67%

6M Performance:

-48.74%

1Y Performance:

-52.42%

1-Day Range:

$17.67

$18.18

1-Week Range:

$17.07

$18.22

52-Week Range:

$16.96

$45.42

Integra Lifesciences Holdings Corp Stock (IART) Company Profile

Name

Integra Lifesciences Holdings Corp

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

(609) 275-0500

Address

1100 CAMPUS ROAD, PRINCETON, NJ

Employee

3,946

Twitter

@integra_life

Next Earnings Date

2024-10-23

Latest SEC Filings

IART's Discussions on Twitter

Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-05-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Nov-14-23	Initiated	CL King	Buy
Aug-24-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jul-12-23	Upgrade	Jefferies	Hold → Buy
Jun-08-23	Downgrade	Argus	Buy → Hold
May-24-23	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Downgrade	Citigroup	Neutral → Sell
Oct-12-22	Initiated	Jefferies	Hold
Jul-25-22	Initiated	Morgan Stanley	Equal-Weight
Apr-13-22	Downgrade	Truist	Buy → Hold
Dec-17-21	Upgrade	JP Morgan	Underweight → Neutral
Sep-15-21	Downgrade	BTIG Research	Buy → Neutral
Oct-08-20	Downgrade	JP Morgan	Neutral → Underweight
May-27-20	Initiated	Citigroup	Neutral
Apr-03-20	Initiated	SunTrust	Buy
Jan-07-20	Downgrade	Piper Jaffray	Overweight → Neutral
Jan-07-20	Downgrade	Piper Sandler	Overweight → Neutral
Jan-03-19	Initiated	SunTrust	Buy
Nov-28-18	Initiated	UBS	Neutral
Aug-07-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-18	Upgrade	BTIG Research	Neutral → Buy
Jul-02-18	Downgrade	Citigroup	Buy → Neutral
Jan-05-18	Resumed	Cantor Fitzgerald	Neutral
Jan-02-18	Downgrade	BofA/Merrill	Buy → Neutral
Nov-09-17	Reiterated	RBC Capital Mkts	Sector Perform
Oct-30-17	Downgrade	Wells Fargo	Outperform → Market Perform
Oct-27-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-30-17	Initiated	Cantor Fitzgerald	Overweight
May-02-17	Reiterated	RBC Capital Mkts	Sector Perform
Jan-13-17	Reiterated	RBC Capital Mkts	Sector Perform
Jan-06-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Dec-12-16	Initiated	UBS	Buy

View All

Integra Lifesciences Holdings Corp Stock (IART) Latest News

02:27 AM

Checking in on Integra Lifesciences Holdings Corp (IART) after recent insiders movement - Knox Daily

02:27 AM

02:04 AM

Does Integra Lifesciences Holdings Corp (IART) offer a good opportunity for investors? - SETE News

02:04 AM

06:00 AM

Veterinary Arthroscopy Device Market is Predicted to Reach US$ 721.9 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.

06:00 AM

04:59 AM

Axa S.A. Has $2.82 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat

04:59 AM

Sep 26, 2024

Investor’s Toolkit: Key Ratios for Assessing Integra Lifesciences Holdings Corp (IART)’s Performance - The Dwinnex

Sep 26, 2024